Literature DB >> 1546325

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

M Mahadevan1, C Tsilfidis, L Sabourin, G Shutler, C Amemiya, G Jansen, C Neville, M Narang, J Barceló, K O'Hoy.   

Abstract

Myotonic dystrophy (DM) is the most common inherited neuromuscular disease in adults, with a global incidence of 1 in 8000 individuals. DM is an autosomal dominant, multisystemic disorder characterized primarily by myotonia and progressive muscle weakness. Genomic and complementary DNA probes that map to a 10-kilobase Eco RI genomic fragment from human chromosome 19q13.3 have been used to detect a variable length polymorphism in individuals with DM. Increases in the size of the allele in patients with DM are now shown to be due to an increased number of trinucleotide CTG repeats in the 3' untranslated region of a DM candidate gene. An increase in the severity of the disease in successive generations (genetic anticipation) is accompanied by an increase in the number of trinucleotide repeats. Nearly all cases of DM (98 percent or 253 of 258 individuals) displayed expansion of the CTG repeat region. These results suggest that DM is primarily caused by mutations that generate an amplification of a specific CTG repeat.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546325     DOI: 10.1126/science.1546325

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  503 in total

1.  Patterns of instability of expanded CAG repeats at the ERDA1 locus in general populations.

Authors:  R Deka; S Guangyun; J Wiest; D Smelser; S Chunhua; Y Zhong; R Chakraborty
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

3.  Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation.

Authors:  G Raca; E Y Siyanova; C T McMurray; S M Mirkin
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; J Gehrmann; S Reddy
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 5.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 6.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

7.  Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.

Authors:  M S Zinkernagel; S J Hornby; R E MacLaren
Journal:  Eye (Lond)       Date:  2012-10-05       Impact factor: 3.775

8.  Solution structure of the RNA binding domain in the human muscleblind-like protein 2.

Authors:  Fahu He; Weirong Dang; Chikage Abe; Kengo Tsuda; Makoto Inoue; Satoru Watanabe; Naohiro Kobayashi; Takanori Kigawa; Takayoshi Matsuda; Takashi Yabuki; Masaaki Aoki; Eiko Seki; Takushi Harada; Yuri Tomabechi; Takaho Terada; Mikako Shirouzu; Akiko Tanaka; Peter Güntert; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

Review 9.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

10.  Paternal transmission of congenital myotonic dystrophy.

Authors:  J Bergoffen; J Kant; J Sladky; D McDonald-McGinn; E H Zackai; K H Fischbeck
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.